Liposome modified by transferrin and RGD for glioma targeting
|更新时间:2025-01-15
|
Liposome modified by transferrin and RGD for glioma targeting
Journal of Army Medical UniversityVol. 36, Issue 6, Pages: 592-595(2014)
作者机构:
无锡市人民医院神经外科
作者简介:
基金信息:
DOI:
CLC:R341;R735.7;R394-33
Published:2014,
Published Online:30 March 2014,
稿件说明:
移动端阅览
SHAO YUN, YU XIANGRONG, WU YIPING, et al. Liposome modified by transferrin and RGD for glioma targeting. [J]. Journal of army medical university, 2014, 36(6): 592-595.
DOI:
SHAO YUN, YU XIANGRONG, WU YIPING, et al. Liposome modified by transferrin and RGD for glioma targeting. [J]. Journal of army medical university, 2014, 36(6): 592-595.DOI:
Liposome modified by transferrin and RGD for glioma targeting
Objective To prepare liposomes co-modified by transferrin and Arg-Gly-Asp (RGD) and to evaluate their glioma-targeting efficiency
in vitro
and
in vivo
. Methods The co-modified liposome was prepared by film-ultrasonic method. The appearance
particle size
and Zeta potential were evaluated. The cellular uptake by U87 cells
in vitro
and
in vivo
imaging were used to evaluate the targeting efficiency. Results The particle diameter of the co-modified liposome was 120.0±8.5 nm with the Zeta potential of -5.00±1.15 mV. The results demonstrated that the co-modified liposome uptaken by U87 were 2.1 and 2.7 time
s higher than that of transferrin-modified liposome and RGD-modified liposome
respectively. The evaluation of tumor spheroid penetration and
in vivo
imaging showed the co-modified liposome had the strongest fluorescence intensity. Conclusion The co-modified liposome might serve as a promising glioma delivery system of antitumor drugs.